» Articles » PMID: 33444603

Reinforcing Effects of Synthetic Cathinones in Rhesus Monkeys: Dose-response and Behavioral Economic Analyses

Overview
Publisher Elsevier
Date 2021 Jan 14
PMID 33444603
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The abuse of synthetic cathinones ("bath salts") with psychomotor stimulant and/or entactogenic properties emerged as a public health concern when they were introduced as "legal" alternatives to drugs of abuse such as cocaine or MDMA. In this study, experiments were conducted in nonhuman primates to examine how differences in transporter selectivity might impact the reinforcing effects of synthetic cathinones. Rhesus monkeys (N = 5) were trained to respond for intravenous injections under a fixed-ratio (FR) 30, timeout 60-s schedule of reinforcement. The reinforcing effects of selected cathinones (e.g., MDPV, αPVP, MCAT, and methylone) with a range of pharmacological effects at dopamine and serotonin transporters were compared to cocaine and MDMA using dose-response analysis under a simple FR schedule and behavioral economic procedures that generated demand curves for two doses of each drug. Results show that one or more doses of all drugs were readily self-administered in each subject and, excepting MDMA (21 injections/session), peak levels of self-administration were similar across drugs (between 30 and 40 injections/session). Demand elasticity for the peak and the peak + 1/2-log dose of each drug did not significantly differ, and when data for the two doses were averaged for each drug, the following rank-order of reinforcing strength emerged: cocaine > MCAT = MDPV = methylone > αPVP = MDMA. These results indicate that the reinforcing strength of synthetic cathinones are not related to their selectivity in binding dopamine or serotonin transporter sites.

Citing Articles

Comparative Assessment of the Addictive Potential of Synthetic Cathinones by Zebrafish Conditioned Place Preference (CPP) Paradigm.

Chen L, Chan M, Chen H Life (Basel). 2024; 14(7).

PMID: 39063573 PMC: 11278444. DOI: 10.3390/life14070820.


Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective.

Chen S, Zhou W, Lai M Brain Sci. 2024; 14(4).

PMID: 38671986 PMC: 11048581. DOI: 10.3390/brainsci14040334.


Impacts of Self-Administered 3,4-Methylenedioxypyrovalerone (MDPV) Alone, and in Combination with Caffeine, on Recognition Memory and Striatal Monoamine Neurochemistry in Male Sprague Dawley Rats: Comparisons with Methamphetamine and Cocaine.

Seaman Jr R, Lamon K, Whitton N, Latimer B, Sulima A, Rice K Brain Sci. 2024; 14(3).

PMID: 38539646 PMC: 10969043. DOI: 10.3390/brainsci14030258.


Prefrontal-Limbic Circuitry Is Associated With Reward Sensitivity in Nonhuman Primates.

Hur K, Meisler S, Yassin W, Frederick B, Kohut S Biol Psychiatry. 2024; 96(6):473-485.

PMID: 38432521 PMC: 11338745. DOI: 10.1016/j.biopsych.2024.02.1011.


Impacts of Self-Administered 3,4-Methylenedioxypyrovalerone (MDPV) Alone, and in Combination with Caffeine, on Recognition Memory and Striatal Monoamine Neurochemistry in Male Sprague-Dawley Rats: Comparisons with Methamphetamine and Cocaine.

Seaman Jr R, Lamon K, Whitton N, Latimer B, Sulima A, Rice K bioRxiv. 2024; .

PMID: 38352595 PMC: 10862826. DOI: 10.1101/2024.01.31.578247.


References
1.
Foster T, Temple W, Cameron B, Poling A . Demand curves for food in hens: Similarity under fixed-ratio and progressive-ratio schedules. Behav Processes. 2014; 39(2):177-85. DOI: 10.1016/s0376-6357(96)00051-4. View

2.
Gannon B, Galindo K, Rice K, Collins G . Individual Differences in the Relative Reinforcing Effects of 3,4-Methylenedioxypyrovalerone under Fixed and Progressive Ratio Schedules of Reinforcement in Rats. J Pharmacol Exp Ther. 2017; 361(1):181-189. PMC: 5363773. DOI: 10.1124/jpet.116.239376. View

3.
Marusich J, Antonazzo K, Wiley J, Blough B, Partilla J, Baumann M . Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. 2014; 87:206-13. PMC: 4152390. DOI: 10.1016/j.neuropharm.2014.02.016. View

4.
Simmler L, Buser T, Donzelli M, Schramm Y, Dieu L, Huwyler J . Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2012; 168(2):458-70. PMC: 3572571. DOI: 10.1111/j.1476-5381.2012.02145.x. View

5.
Glowa J, Rice K, Matecka D, Rothman R . Phentermine/fenfluramine decreases cocaine self-administration in rhesus monkeys. Neuroreport. 1997; 8(6):1347-51. DOI: 10.1097/00001756-199704140-00006. View